Founded in 2013, Lunit (KRX:328130.KQ) is a global leader in AI for cancer diagnostics and therapeutics. With a mission to conquer cancer through AI, Lunit develops AI-powered solutions for medical imaging and biomarker analysis to enable precise diagnosis and personalized treatment. Lunit’s FDA-cleared Lunit INSIGHT suite supports cancer screening at over 6,500 medical institutions in more than 65 countries. The company acquired Volpara Health, bringing together world-leading science and intelligent AI for early detection, mammography quality compliance, and cancer risk into a single, comprehensive ecosystem. Lunit clinical studies have been featured in top-tier journals—including The Lancet Digital Health and Journal of Clinical Oncology—and presented at major conferences such as ASCO and RSNA. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io.
LuckyEng
Unlock Excellence with LUCKY ENG: Your Expert Partner in Automated Food SolutionsLucky Eng offers innovative automated food machines that empower anyone to become an expert in making gimbap and sushi. We are dedicated to delivering futuristic concepts and top-notch quality products to our valued customers. Founded in 1992, we specialized in developing and delivering high-quality machines that automate the production of gimbap and sushi. Today, our machines are trusted by major companies and widely used in many stores across South Korea, where we proudly hold 90% of the domestic market share. Our commitment to excellence drives us to export our machines globally. â Gimbap/Sushi Roll Machine and CutterOur gimbap machine is expertly designed to accommodate the distinctive style of Korean gimbap, which features a variety of fillings wrapped in a thin layer of rice and seaweed. Whether you’re using various kinds of ingredient such as meats, vegetables, avocados, or pork cutlets and so forth, this machine can handle it all. When making gimbap by hand, precision is keyâfrom spreading the cooked rice evenly on the seaweed, adding filling ingredients, and rolling it tightly with just the right pressure. Each grain of rice should remain intact, without being pressed, to achieve the perfect texture. Our machine ensures that rice is spread evenly and can adjust its rolling pressure according to the type of filling used. This guarantees that both soft and hard ingredients maintain their ideal textures and condition. The gimbap machine features an anti-stick coating surface in the rice contact area and is constructed from durable stainless steel, ensuring longevity and safety. The integrated safety features in the machine help maintain a secure kitchen environment.The gimbap cutter is engineered to cut ingredients of various sizes with precision and efficiency, while prioritizing safety.This innovative tool not only minimizes labor costs and reduces the intensity of manual tasks, but it also significantly enhances productivity and improves overall quality.â Sushi Machines and Rice DispensersWe also offer a range of sushi machines and rice dispensers designed for ease and efficiency. Our sushi machines are perfectly suited for customers around the world, equipped with an automatic wasabi function and a user-friendly touch screen for simple operation. With precise adjustments for weight, density, and wasabi amount, you can create beautiful sushi dishes every time. Our rice dispensers ensure a sanitary, efficient solution for cafeterias and restaurants, delivering consistent and accurate rice distribution. Clients from hospitals, schools, and corporate cafeterias praise our machines for their reliability and effectiveness. We invite you to visit our booth to explore how our dependable and innovative automatic machines can enhance your kitchen experience. Thank you.
LUCEM Corporation
The only Korean Anode Rotating X-Ray tube assembly manufacturer.
LSK Global PS
LSK Global PS delivers a comprehensive, end-to-end clinical development model built on 26 years of industry experience, aligning strategy, operations, data, and regulatory functions to minimize delays, reduce risk, and ensure quality. Unified workflows across clinical operations, data management, and biostatistics enable efficient execution and timely submissions, while pharmacovigilance and medical writing are seamlessly incorporated to support submission-ready deliverables. Combined with academic and epidemiological expertise and extensive domestic and global trial experience, this approach strengthens regulatory readiness and supports successful clinical development in Korea.
LS ELECTRIC America
LS ELECTRIC America delivers cutting-edge automation, power distribution, and smart energy solutions tailored for HVAC and industrial markets. With deep global roots and a strong U.S. presence, we empower customers through innovation, reliability, and sustainability. From advanced VFDs to intelligent control systems, our technology drives efficiency and performance. Backed by decades of expertise and a commitment to excellence, LS ELECTRIC America is your trusted partner for powering the future.
LS ELECTRIC
LS ELECTRIC provides a power system and automated solution for efficiency and sustainability. We are creating an abundant future by delivering safe clean energy. In line with a manufacturing trend for smart factories and a bigger emphasis on energy solutions, we have been shifting from a device maker to a solutions provider that offers a platform combining hardware and software. We are leading the way towards a new future through innovations that exceed our customer’s expectations. | LS ELECTRIC is a leading company specializing in electric power solutions and automation systems. It provides a wide range of products and services, including power distribution and control systems, smart grids, renewable energy solutions, and industrial automation technologies. With a strong focus on innovation and sustainability, LS ELECTRIC offers eco-friendly and efficient solutions to meet the evolving needs of industries worldwide. The company is also known for its smart energy management systems, which help businesses improve operational efficiency and reduce environmental impact. | LS ELECTRIC provides a power system and automated solution for efficiency and sustainability. We are creating an abundant future by delivering safe clean energy.
LS e-Mobility Solutions
It is a South Korean company with roots in the LG Group, famous for its TVs. We produce high-voltage, high-performance DC relays (Contactor) for use in vehicles. We have been supplying EV relays to global OEMs for 20 years with a dedicated development team since 2005, before electric vehicles were commercialized. Our another representative product is the BDU (Battery Disconnect Unit), which is also called PRA (Power Relay Assembly). Yes, LS e-Mobility Solutions guarantees performance beyond your expectations.
LOTTE BIOLOGICS
LOTTE BIOLOGICS is a global CDMO company committed to provide good quality biopharmaceutical products that enable a healthier world. Since established in 2022, with unwavering dedication and distinction, LOTTE BIOLOGICS has successfully transformed into a global CDMO company following the acquisition of Bristol Myers Squibb’s Syracuse manufacturing site. Furthermore, with a plan for Mega Plants in Korea with a total capacity exceeding 360,000L, LOTTE BIOLOGICS aims to become a Global Top 10 CDMO company in the biopharmaceutical industry. In terms of capabilities, LOTTE BIOLOGICS can offer a comprehensive range of services, from cell line development to clinical and commercial supply of Biologics Drug Substance manufacturing. The production capacity at the Syracuse site is 35,000L (5,000L x7), along with multiple 1,100 L bioreactors for clinical product production, QC testing laboratories, a warehouse, cell bank and product storage and other related facilities. In addition, the Syracuse site has a proven regulatory track record with more than 62 global approvals including from FDA, EMA, PMDA and MFDS. In addition, ADC conjugation facility is currently being installed to meet the increasing demand in the market. The Mega Plants in South Korea, with a total capacity exceeding 360,000L, are scheduled to be GMP ready starting from the year of 2026. In order to foster growth and innovation in the biopharmaceutical industry, “LOTTE Bio Initiatives” will be established on the Mega Plant Campus to provide a platform for bioecosystem. Together with our partners, LOTTE BIOLOGICS is dedicated to providing reliable solution for development, manufacturing and supply of the biopharmaceutical products. For more information, please visit https://www.lottebiologics.com/en | LOTTE BIOLOGICS is a global CDMO company committed to provide good quality biopharmaceutical products that enable a healthier world. Since established in 2022, with unwavering dedication and distinction, LOTTE BIOLOGICS has successfully transformed into a global CDMO company following the acquisition of Bristol Myers Squibb’s Syracuse manufacturing site. Furthermore, with a plan for Songdo Bio Campus in Korea with a total capacity up to 360,000L, LOTTE BIOLOGICS aims to become a Global Top 10 CDMO company in the biopharmaceutical industry. In terms of capabilities, LOTTE BIOLOGICS can offer a comprehensive range of services, from cell line development to clinical and commercial supply of Biologics Drug Substance manufacturing. The production capacity at the Syracuse Bio Campus is 40,000L (5,000L x8), along with multiple 1,100 L bioreactors for clinical product production, QC testing laboratories, a warehouse, cell bank and product storage and other related facilities. In addition, the Syracuse Bio Campus has a proven regulatory track record with more than 62 global approvals including from FDA, EMA, PMDA and MFDS. In addition, ADC conjugation facility is currently being installed to meet the increasing demand in the market, which is projected to be fully in operation by Q1 2025. The Songdo Bio Campus in South Korea, with a total capacity up to 360,000L, are scheduled to be GMP ready starting from the year of 2026. In order to foster growth and innovation in the biopharmaceutical industry, “LOTTE Bio Initiatives” will be established on the Songdo Bio Plant Campus to provide a platform for bioecosystem. Together with our partners, LOTTE BIOLOGICS is dedicated to providing reliable solution for development, manufacturing and supply of the biopharmaceutical products. For more information, please visit https://www.lottebiologics.com/en | LOTTE BIOLOGICS was established in 2022 and is headquartered in Seoul, South Korea. Utilizing a two-track strategy of acquiring and building, LOTTE BIOLOGICS is solidifying its competitiveness in the CDMO market. At the Syracuse Bio Campus in New York, LOTTE BIOLOGICS provides high-quality GMP manufacturing services for drug substances. The facility offers a total production capacity of 40,000L, supported by eight 5,000L stainless steel bioreactors. Additionally, the campus includes extensive analytical QC testing laboratories and warehouse facilities that have received over 62 regulatory approvals from agencies worldwide. LOTTE BIOLOGICS is also advancing into a new area of expertise with Antibody-Drug Conjugates (ADCs) services. With over $100 million invested in ADC modalities, including both drug substance and conjugation capabilities on-site, we offer a seamless, end-to-end service from drug substance manufacturing to conjugation. Looking ahead, LOTTE BIOLOGICS is constructing three advanced bio plants in Songdo, South Korea. With construction of the first plant already underway and expected to be operational by 2027, each facility will feature eight 15,000L stainless steel bioreactors for large-scale commercial production, along with multiple 3,000L bioreactors to meet clinical production needs. Collectively, these plants will provide a manufacturing volume exceeding 360,000L in bioreactor capacity. Through our commitment to delivering innovative medicines to patients worldwide, LOTTE BIOLOGICS aims to become a top-tier global CDMO company in the biopharmaceutical industry.